Search
Merck & Co Inc
MRKAdd to Watchlist
113.870USD
-1.550-1.34%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
281.22BMarket Cap
31.92P/E TTM
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Oncology-Keytruda
31.64B
48.67%
Vaccines -Gardasil/Gardasil
5.23B
8.05%
Animal Health-Livestock
3.90B
5.99%
Other pharmaceutical
2.92B
4.49%
Animal Health-Companion Animals
2.46B
3.78%
Other
18.86B
29.02%
By RegionUSD
Name
Revenue
Proportion
United States
36.51B
56.16%
Europe, Middle East and Africa
14.58B
22.43%
Latin America
3.41B
5.25%
Asia Pacific (Other than China and Japan)
2.98B
4.59%
Other
2.88B
4.43%
Other
4.65B
7.15%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Oncology-Keytruda
31.64B
48.67%
Vaccines -Gardasil/Gardasil
5.23B
8.05%
Animal Health-Livestock
3.90B
5.99%
Other pharmaceutical
2.92B
4.49%
Animal Health-Companion Animals
2.46B
3.78%
Other
18.86B
29.02%
